Navigation Links
AbbVie's Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
Date:5/6/2013

-formulated tablets of ABT-450/r and ABT-267 are being used in the Phase 3 trials.

About the Hepatitis C Virus  Across the world, about 160 million people are chronically infected with hepatitis C.(2) Hepatitis C is an inflammation of the liver caused by an infection with the hepatitis C virus (HCV).(3)  HCV is transmitted when an infected person's blood enters the bloodstream of another person.(4)

For the hepatitis C virus, there are six major HCV genotypes (GT1-6).(5) Presently, there is no vaccine for the hepatitis C virus (HCV) infection.(5) Decision to treat is dependent on a number of factors such as the amount of liver damage present, other conditions the patient may have, amount of virus in the body, and viral genotype.(5) If treatment is needed, a hepatitis C infection is typically treated with a combination of antivirals.(5)

About AbbVie's HCV Development ProgramsAbbVie's HCV portfolio includes investigational medicines with three different mechanisms of action, including protease (ABT-450/r), polymerase (ABT-333) and NS5A (ABT-267) inhibitors, currently being studied in clinical trials. ABT-450 is being developed with low dose ritonavir which enhances the pharmacokinetic properties of ABT-450. The use of ritonavir 100mg with ABT-450 for the treatment of HCV is investigational.

ABT-450 was discovered during the course of a collaboration between AbbVie and Enanta Pharmaceuticals for HCV protease inhibitors and regimens that include protease inhibitors. ABT-450 is being developed by AbbVie for use in combination with AbbVie's other investigational medicines for the treatment of HCV. AbbVie is well-positioned to explore combinations and co-formulations of these medicines.

Ritonavir Use in the Treatment of HIVRitonavir is in a class of medicines called the HIV protease inhibitors. Ritonavir is used in combination with other anti-
'/>"/>

SOURCE AbbVie
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia
2. Bayers Investigational Riociguat Granted U.S. FDA Priority Review for Pulmonary Arterial Hypertension and Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
3. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
4. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
5. Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment
6. Genocea Publishes Preclinical Data For Investigational Vaccine Candidate For HSV-2
7. Noven Announces FDA Advisory Committee Vote on Investigational Low-Dose Mesylate Salt of Paroxetine (LDMP) for Vasomotor Symptoms Associated with Menopause
8. Scioderms Investigational New Drug (IND) Application for SD-101 for Treatment of Epidermolysis Bullosa (EB) Allowed by the FDA
9. BHR Pharma Investigational Traumatic Brain Injury Treatment Receives European Medicines Agency Orphan Medicinal Product Designation
10. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
11. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014 The number ... killing 45 people each day. Twenty-three percent of the ... Survey on Drug Use and Health, making opioid use ... are taking opioid painkillers at the correct dosage with ... Today, the National Safety Council ...
(Date:7/22/2014)... VIEW, Calif. , July 22, 2014 /PRNewswire/ ... resonance imaging (MRI) market, Frost & Sullivan recognizes ... for Product Leadership. Siemens Healthcare,s FREEZEit solution, which ... the need for robust and motion-insensitive imaging. The ... boosted the evolution of body MRI imaging in ...
(Date:7/22/2014)... -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN ... first lots of Fluzone ® (Influenza Vaccine) for the ... U.S. Food and Drug Administration (FDA) for distribution. The lots ... at least 65 million doses of seasonal influenza vaccine manufactured ... care providers and pharmacies in August. The ...
Breaking Medicine Technology:5 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 2Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 2Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 3Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 5Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 6Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 7
... Personal Experience about Protecting Kids from a Deadly ... but Vaccine-Preventable Disease, ... (PKIDs) today announced the launch of its national educational,campaign "Silence ... To view the Multimedia News Release, go to:, http://www.prnewswire.com/mnr/pertussis/29579/ ...
... MIAMI, Oct. 16 Roger K. Khouri, M.D. ... a team of surgeons in a,clinical trial performing ... external expansion system and liposuctioned,micro-fat grafts primarily on ... or without radiation therapy. Typically, breast reconstruction ...
Cached Medicine Technology:Video: Actress and New Mom Keri Russell Joins PKIDs to Launch 'Silence the Sounds of Pertussis' Campaign 2Video: Actress and New Mom Keri Russell Joins PKIDs to Launch 'Silence the Sounds of Pertussis' Campaign 3New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study 2
(Date:7/23/2014)... Previously, the crew members for Maplewood’s three fire ... Now, the department’s 53 part-time members “self-schedule” through the ... , “Scheduling our personnel with paper and pencil, and then ... track of when people could work, because they would say ... and we would have to try to figure out how ...
(Date:7/23/2014)... Controlling pain during childbirth and post delivery may reduce ... a Northwestern Medicine perinatal psychiatrist, in a July 23 ... Wisner,s editorial is based on a new Chinese study ... anesthesia during a vaginal delivery had a much lower ... the epidural. , "Maximizing pain control in labor and ...
(Date:7/22/2014)... July 22, 2014 Print Audit® ... Audit Facilities Manager web portal. Facilities Manager 3.1.0R ... of the software as well as numerous new ... Print Audit Facilities Manager is a powerful, easy ... remotely collect meter reads, automate supplies fulfillment and ...
(Date:7/22/2014)... Recently, iFitDress.com, a popular supplier of wedding dresses ... selection of white party dresses to its product ... are now available on its website. As a special offer, ... July can get a discounted rate, up to 54% off. ... international customers, so its marketing specialist believes the new white ...
(Date:7/22/2014)... (PRWEB) July 23, 2014 Provectus ... devices . From now on, in addition to working ... software solutions for Google Glass as well as the ... , A dynamic lifestyle requires special gadgets for ... Glass has found application in healthcare, logistics, travelling, sports, ...
Breaking Medicine News(10 mins):Health News:This Fire Department Allows Personnel to Schedule Themselves - Saving Administration Up To 60 Hours a Month 2Health News:This Fire Department Allows Personnel to Schedule Themselves - Saving Administration Up To 60 Hours a Month 3Health News:Controlling childbirth pain tied to lower depression risk 2Health News:Print Audit® Releases Facilities Manager 3.1.0R 2Health News:Elegant White Party Dresses Now Provided by Distinguished Company iFitDress.com 2Health News:Provectus Announces Development for Google Glass and Wearables 2
... A form of partial epilepsy associated with auditory ... disruption of brain development during early childhood, according to ... Medical Center (BIDMC). , Described in today,s Advance On-line ... provide the first genetic link between childhood brain development ...
... ... of Washington D.C. is business owner John Wahlquist of eMedicalSystems, Bremerton, Washington state. Author of ... unusual choice to retire his product and migrate his medical practices over to a new ... ...
... LOUISVILLE, Ky., Aug. 22 A top medical officer in the ... veterans service organizations can play a key role in suicide prevention ... coordinator, in pointing to the 5,000 self-inflicted deaths among veterans a ... to own up to that. There,s no reason any veteran in ...
... check-ups and communication with school staff , SATURDAY, Aug. 22 ... parents of children with asthma can prepare for flu season ... , "Good hygiene is the best and first line of ... frequent handwashing and covering your mouth when coughing or sneezing," ...
... CAESAREA, Israel, August 17 EndyMed Medical Ltd, an,innovative ... market, announced today the FDA clearance of the EndyMed,PRO(TM) ... rhytides. , The EndyMed PRO ... uses multiple, phase controlled sources, and is the,first product ...
... The nation,s home foreclosure epidemic may be taking its ... Nearly half of people studied while undergoing foreclosure reported ... major depression, according to new University of Pennsylvania School ... American Journal of Public Health. Many also ...
Cached Medicine News:Health News:Fragile period of childhood brain development could underlie epilepsy 2Health News:eMedical Systems, Inc. Selects MPMsoft as its Medical Billing Software Solution 2Health News:eMedical Systems, Inc. Selects MPMsoft as its Medical Billing Software Solution 3Health News:The American Legion Can Play Key Role in Vets' Suicide Prevention, Says VA 2Health News:Going Back to School With Asthma Takes Extra Work 2Health News:EndyMed Medical Receives FDA Clearance for Painless, Non-invasive Anti-Wrinkle Treatment System 2Health News:More than 1/3 of homeowners in foreclosure suffer from major depression, Penn study shows 2Health News:More than 1/3 of homeowners in foreclosure suffer from major depression, Penn study shows 3
Inquire...
Inquire...
Protects the skin over extended wearing time from irritating discharge. Flextend skin barrier is the barrier of choice for urostomies and ileostomies with the added benefit of it being discreet in bo...
Inquire...
Medicine Products: